Cargando…

Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity

Inhibition of malonyl-coenzyme A decarboxylase (MCD) shifts metabolism from fatty acid towards glucose oxidation, which has therapeutic potential for obesity and myocardial ischemic injury. However, ~ 40% of patients with MCD deficiency are diagnosed with cardiomyopathy during infancy. AIM: To clari...

Descripción completa

Detalles Bibliográficos
Autores principales: Aksentijević, Dunja, McAndrew, Debra J., Karlstädt, Anja, Zervou, Sevasti, Sebag-Montefiore, Liam, Cross, Rebecca, Douglas, Gillian, Regitz-Zagrosek, Vera, Lopaschuk, Gary D., Neubauer, Stefan, Lygate, Craig A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169183/
https://www.ncbi.nlm.nih.gov/pubmed/25066696
http://dx.doi.org/10.1016/j.yjmcc.2014.07.008
_version_ 1782335671559520256
author Aksentijević, Dunja
McAndrew, Debra J.
Karlstädt, Anja
Zervou, Sevasti
Sebag-Montefiore, Liam
Cross, Rebecca
Douglas, Gillian
Regitz-Zagrosek, Vera
Lopaschuk, Gary D.
Neubauer, Stefan
Lygate, Craig A.
author_facet Aksentijević, Dunja
McAndrew, Debra J.
Karlstädt, Anja
Zervou, Sevasti
Sebag-Montefiore, Liam
Cross, Rebecca
Douglas, Gillian
Regitz-Zagrosek, Vera
Lopaschuk, Gary D.
Neubauer, Stefan
Lygate, Craig A.
author_sort Aksentijević, Dunja
collection PubMed
description Inhibition of malonyl-coenzyme A decarboxylase (MCD) shifts metabolism from fatty acid towards glucose oxidation, which has therapeutic potential for obesity and myocardial ischemic injury. However, ~ 40% of patients with MCD deficiency are diagnosed with cardiomyopathy during infancy. AIM: To clarify the link between MCD deficiency and cardiac dysfunction in early life and to determine the contributing systemic and cardiac metabolic perturbations. METHODS AND RESULTS: MCD knockout mice ((−/−)) exhibited non-Mendelian genotype ratios (31% fewer MCD(−/−)) with deaths clustered around weaning. Immediately prior to weaning (18 days) MCD(−/−) mice had lower body weights, elevated body fat, hepatic steatosis and glycogen depletion compared to wild-type littermates. MCD(−/−) plasma was hyperketonemic, hyperlipidemic, had 60% lower lactate levels and markers of cellular damage were elevated. MCD(−/−) hearts exhibited hypertrophy, impaired ejection fraction and were energetically compromised (32% lower total adenine nucleotide pool). However differences between WT and MCD(−/−) converged with age, suggesting that, in surviving MCD(−/−) mice, early cardiac dysfunction resolves over time. These observations were corroborated by in silico modelling of cardiomyocyte metabolism, which indicated improvement of the MCD(−/−) metabolic phenotype and improved cardiac efficiency when switched from a high-fat diet (representative of suckling) to a standard post-weaning diet, independent of any developmental changes. CONCLUSIONS: MCD(−/−) mice consistently exhibited cardiac dysfunction and severe metabolic perturbations while on a high-fat, low carbohydrate diet of maternal milk and these gradually resolved post-weaning. This suggests that dysfunction is a common feature of MCD deficiency during early development, but that severity is dependent on composition of dietary substrates.
format Online
Article
Text
id pubmed-4169183
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Academic Press
record_format MEDLINE/PubMed
spelling pubmed-41691832014-10-01 Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity Aksentijević, Dunja McAndrew, Debra J. Karlstädt, Anja Zervou, Sevasti Sebag-Montefiore, Liam Cross, Rebecca Douglas, Gillian Regitz-Zagrosek, Vera Lopaschuk, Gary D. Neubauer, Stefan Lygate, Craig A. J Mol Cell Cardiol Original Article Inhibition of malonyl-coenzyme A decarboxylase (MCD) shifts metabolism from fatty acid towards glucose oxidation, which has therapeutic potential for obesity and myocardial ischemic injury. However, ~ 40% of patients with MCD deficiency are diagnosed with cardiomyopathy during infancy. AIM: To clarify the link between MCD deficiency and cardiac dysfunction in early life and to determine the contributing systemic and cardiac metabolic perturbations. METHODS AND RESULTS: MCD knockout mice ((−/−)) exhibited non-Mendelian genotype ratios (31% fewer MCD(−/−)) with deaths clustered around weaning. Immediately prior to weaning (18 days) MCD(−/−) mice had lower body weights, elevated body fat, hepatic steatosis and glycogen depletion compared to wild-type littermates. MCD(−/−) plasma was hyperketonemic, hyperlipidemic, had 60% lower lactate levels and markers of cellular damage were elevated. MCD(−/−) hearts exhibited hypertrophy, impaired ejection fraction and were energetically compromised (32% lower total adenine nucleotide pool). However differences between WT and MCD(−/−) converged with age, suggesting that, in surviving MCD(−/−) mice, early cardiac dysfunction resolves over time. These observations were corroborated by in silico modelling of cardiomyocyte metabolism, which indicated improvement of the MCD(−/−) metabolic phenotype and improved cardiac efficiency when switched from a high-fat diet (representative of suckling) to a standard post-weaning diet, independent of any developmental changes. CONCLUSIONS: MCD(−/−) mice consistently exhibited cardiac dysfunction and severe metabolic perturbations while on a high-fat, low carbohydrate diet of maternal milk and these gradually resolved post-weaning. This suggests that dysfunction is a common feature of MCD deficiency during early development, but that severity is dependent on composition of dietary substrates. Academic Press 2014-10 /pmc/articles/PMC4169183/ /pubmed/25066696 http://dx.doi.org/10.1016/j.yjmcc.2014.07.008 Text en © 2014 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/) .
spellingShingle Original Article
Aksentijević, Dunja
McAndrew, Debra J.
Karlstädt, Anja
Zervou, Sevasti
Sebag-Montefiore, Liam
Cross, Rebecca
Douglas, Gillian
Regitz-Zagrosek, Vera
Lopaschuk, Gary D.
Neubauer, Stefan
Lygate, Craig A.
Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity
title Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity
title_full Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity
title_fullStr Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity
title_full_unstemmed Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity
title_short Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity
title_sort cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme a decarboxylase (mcd) knockout mice as a consequence of restricting substrate plasticity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169183/
https://www.ncbi.nlm.nih.gov/pubmed/25066696
http://dx.doi.org/10.1016/j.yjmcc.2014.07.008
work_keys_str_mv AT aksentijevicdunja cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity
AT mcandrewdebraj cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity
AT karlstadtanja cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity
AT zervousevasti cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity
AT sebagmontefioreliam cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity
AT crossrebecca cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity
AT douglasgillian cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity
AT regitzzagrosekvera cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity
AT lopaschukgaryd cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity
AT neubauerstefan cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity
AT lygatecraiga cardiacdysfunctionandperiweaningmortalityinmalonylcoenzymeadecarboxylasemcdknockoutmiceasaconsequenceofrestrictingsubstrateplasticity